Healthcare -
Biotechnology - NASDAQ - US
$ 7.675
-2.23 %
$ 407 M
Market Cap
-3.69
P/E
STOK - DEPRECIATION & AMORTIZATION
Depreciation & Amortization STOK - Stoke Therapeutics, Inc.
2.47 M
LAST VALUE
59.21%
2 YEAR CAGR
63.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR